Trial Testing Oral Therapy Anle138b Now Enrolling Patients in UK

Trial Testing Oral Therapy Anle138b Now Enrolling Patients in UK

303079

Trial Testing Oral Therapy Anle138b Now Enrolling Patients in UK

A Phase 1 clinical trial in the U.K. is recruiting patients with mild to moderate Parkinson’s to assess MODAG Neuroscience Solutions‘ investigational oral therapy anle138b, which seeks to slow or halt disease progression. The trial (NCT04685265) will be conducted at a single site at Nottingham University Hospital, in central England, according to a press release from Cure Parkinson’s. Researchers are looking to enroll 24 adults, ages 50 to 80, who are able to walk unaided. More information on…

You must be logged in to read/download the full post.